ABSTRACT Blot hybridization analysis that used labeled tubulin cDNA probes revealed that N6,02-dibutyryladenosine 3',5'-cyclic monophosphate [dibutyryl cyclic AMP (Bt2cAMP)] initially increases and later decreases the level of tubulin mRNA in a neuroblastoma-glioma hybrid cell line as well as in the parent cells. A significant increase in tubulin mRNA sequences is already evident 1 hr after the addition of Bt2cAMP to the neuroblastoma cells, and a maximal induction of 2-fold is seen after 12 hr. Continued treatment with Bt2cAMP for 4 days results in a down-regulation of the initial tubulin mRNA level independently of cell density. In the glioma cells Bt2cAMP also rapidly increases the level of tubulin mRNA sequences, reaching a maximum within 6 hr. However, in these cells the subsequent decrease in tubulin mRNA content depends on the culture's phase of growth: cells at the logarithmic growth phase do not down-regulate the tubulin mRNA content even after prolonged treatment with Bt2cAMP, whereas confluent cells do. The hybrid cell line manifests intermediate characteristics in Bt2cAMP regulation of tubulin mRNA level. The time course of induction and down-regulation of tubulin mRNA content observed in the hybrid cells is similar to that of the parent neuroblastoma, whereas the sensitivity to induction is glioma-like and is 8-fold over the initial level. Blot hybridization with labeled actin cDNA probes showed a similar but not identical induction of actin mRNA synthesis with the hybrid and glioma cells, whereas no significant change was observed with the neuroblastoma cells. Moreover, prolonged treatment with Bt2cAMP of all these cell lines did not result in down-regulation of actin mRNA sequences below the initial control value. It was also observed that the level of tubulin sequences in mRNA isolated from 12-day-old rat brain was higher than that in the newborn brain. However, at an age of 30 days, the level of tubulin sequences decreases to about 75% of the newborn level.
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Tubulin and actin are the main protein constituents of microtubules and microfilaments. Their expression is modulated in response to external factors or to conditions related to cell differentiation. Qualitative and quantitative changes in the expression of tubulin-both on the mRNA level and in terms of protein microheterogeneity-have been demonstrated during brain maturation (1) (2) (3) (4) . Cloned cells originating from nervous tissue provide a suitable model svstem for studying the specific changes that take place during cell differentiation (5) . Mouse neuroblastoma cells (clone N18TG-2) and rat glioma cells (clone C6BU-1), as well as the hvbrid cell line (clone NG108-15) derived from these parental cell lines, differentiate morphologicallv and functionally in response to N6, 2'-dibutvrvladenosine 3',5'-cyclic monophosphate [dibutyrvl cyclic AMP (Bt2-cAMP)] treatment (6) (7) (8) . The morphological changes most likely involve microtubules and microfilaments, because cAMP-induced neurite formation was shown to be blocked bv vinblastine and cytochalasin B (9, 10). The amount of synthesis of these two proteins from polysomal RNAs was found to be lower in Bt2cAMP-treated than in untreated neuroblastoma cells (11) . A reduction in the expression of tubulin and actin prior to the morphological differentiation of 3T3 adipocytes has also been reported (12) and the decrease of mRNA specific for cytoskeletal proteins has been correlated with functional differentiation. On the other hand, morphological changes after interferon treatment of human cell lines were correlated with an increase of tubulin mRNA level (13) . The mRNA Preparation, Cell-Free Translation, and Product Analysis. For each experimental point, 5-10 plates (100 mm) containing 4-6 X 106 cells per plate were used. The cultured cells were chilled and the medium was removed, followed bv two successive washes with cold phosphate-buffered saline and cold RSB (10 mM NaCI/10 mM Tris-HCI, pH 7.3/1.5 mM
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement' in accordance with 18 U. S.C. § 1734 solely to indicate this fact.
4244 Biochemistry: Ginzburg et al.
cell-free products were analyzed by isoelectric focusing and NaDodSO4/10% polyacrylamide two-dimensional electrophoresis (18) . Total brain mRNA was prepared as described (19) .
Analysis of Tubulin and Actin mRNA Levels. A sample of 2 pig of poly(A)-containing RNA was fractionated in 1.2% formaldehyde/agarose denaturing gels. The treatment of samples, blotting of the gel, and hybridization conditions were performed as described (13) . Hybridization was carried out with 32P-labeled nick-translated pT25 a-tubulin cDNA probe and pA72 A-actin probe (19, 20) . After the hybridization the blots were exposed to Agfa Curix RP2 x-ray films at -700C for 2-4 days. Autoradiograms were scanned at 560 nm with a Gilford 2400 S spectrophotometer.
RESULTS
Previous studies have shown that during the first 10 days after birth the percentage of cytoplasmic rat brain tubulin increases somewhat (21) or remains almost constant (22) . Moreover, by about day 10 after birth, there is a progressive decrease in the percentage of cytoplasmic brain tubulin until the rat reaches adulthood (21, 22) . Therefore, it was of interest to determine whether these changes in tubulin are followed by similar modulation of the corresponding mRNA.
Poly(A)-containing mRNA was isolated from brains of newborn, 12-day-old, and 30-day-old rats and quantitation of tubulin-specific sequences was carried out after electrophoretic separation of the mRNA samples in formaldehyde/agarose slab gels. The RNA was then transferred onto a nitrocellulose filter and hybridized with a nick-translated 32P-labeled pT25-tubulin cDNA probe (19, 23) . Fig. 1 shows that a single RNA species (of mobility slightly faster than that of 18S mRNA) hybridized to this tubulin-specific probe. It is clear also that the level of tubulin sequences in mRNA isolated from brains of 12-day-old rats is higher (== 165%) than that in the newborn rat brain. However, at age 30 days, the level of tubulin-specific sequences decreases to mm75% of the newborn level. Thus, the changes in tubulin mRNA levels are even more pronounced than the modulation of tubulin protein levels observed in the developing brain and correlate with the differentiation of neurons, axon formation, and increase in the expression of brain-specific isotubulins (cf. ref. 1). It should be noted that in these experiments, the sum of a-and ,3-tubulin RNAs is scored, because of the great homology between the a-and ,B-tubulin nucleotide sequences in the pT25 cDNA probe used.
The high complexity of brain mRNA is generally interpreted as reflecting the heterogeneity of cell types present in this organ. Cloned cells originating from the nervous system that retain many of the morphologic and physiologic properties of neurons and glia in vivo were therefore used as convenient models for the study of differentiated cell function. Cell cultures of mouse neuroblastoma (clone NG18TG-2), rat glioma (C6BU-1), and their somatic cell hybrid (clone NG108-15) in the logarithmic phase of growth were treated with Bt2cAMP for varying time intervals up to 48 hr. After treatment, poly(A)-containing RNA was prepared from each culture. The results of blot hybridization assays of these mRNA preparations with tubulin cDNA probes are presented in Fig. 2 Conditions were the same as described in Fig. 1 Proc. NatL Acad. Sci. USA 80 (1983) 4245 grams were scanned and quantitatively evaluated as shown in Fig. 2D .
It was found that tubulin mRNA sequences were induced by Bt2cAMP in a time-dependent manner in all three cell lines. In the neuroblastoma and hybrid cells (Fig. 2 A and C , respectively), maximal levels of tubulin (2-fold and 8-fold over control, respectively) were reached 12 hr after the addition of the inducer. However, after 48 hr in the presence of the cyclic nucleotide, the tubulin mRNA content in both of these cell lines dropped to a level that was -50% of the initial control value. In the glioma cells, maximal levels of tubulin mRNA sequences (':z5-fold over control) were induced after 6 hr (Fig. 2B) . In contrast to the down-regulation observed in the hybrid and neuroblastoma cells (i.e., a decline below the levels observed in untreated cells), the tubulin mRNA content-in glioma cells was still significantly higher at 48 hr as compared to the initial values. In all of these experiments equivalent amounts of poly(A)-containing RNA from the three cell lines were subjected to electrophoresis. In several experiments the range of variation was no more than 5% and the amount of hybridization was linear with RNA input.
The same RNA blots presented in Fig. 2 were later used to follow the changes in another cytoskeletal protein-namely, actin. After a 2-month period, during which time the radioactivity of the 32P-labeled tubulin cDNA had decayed to a low level, the blots were rehybridized with 3P-labeled pA72 actin cDNA (19) . As seen in Fig. 3 , the mRNA levels in the glioma and the hybrid cells but not in the neuroblastoma cells were increased during the early phase of Bt2cAMP treatment. After 48 hr in the presence of the cyclic nucleotide, the level of actin mRNA decreased to its initial value in the hybrid cells, but it remained at its maximal induced level in the glioma cells. In the neuroblastoma cells the actin mRNA levels did not change significantly within the 48 hr, the period during which the cells were exposed to the inducer.
Because the glioma cells in the exponential phase of growth did not appear to down-regulate tubulin mRNA in response to 20 were treated with Bt2cAMP at the logarithmic (Log.) and confluent (Conf.) phase of growth for 48 hr. The analysis of the mRNA isolated from these cells was performed as described in the legend to Fig. 1 . The autoradiograms were scanned and the intensities of the spots are presented relative to that found with mIRNA from the untreated logarithmic phase cells.
Bt2cAMP (Fig. 2 B and D) , this effect was reinvestigated in both glioma and neuroblastoma cells grown for 4 days in the presence of the inducer. Our results revealed differences in response of neuroblastoma and glioma cells to Bt2cAMP. The inducer caused a reduction of tubulin mRNA sequences in neuroblastoma cells in both the logarithmic and the confluent phases of growth (Fig. 4A) . However, in glioma cells, only the confluent culture exhibited down-regulation (Fig. 4B) .
To further investigate the biological activity of the mRNA preparations, aliquots of the various preparations were assayed by their translation in a reticulocyte lysate cell-free system. The [S]methionine-labeled products were then analyzed by twodimensional gel electrophoresis. The results shown in Fig. 5 demonstrate a small decrease in both tubulin and actin levels when mRNA was isolated from cells treated for 4 days with Bt2cAMP, which is in accord with the hybridization data. 
DISCUSSION
The results presented in this study demonstrate that tubulin mRNA levels can be both positively and negatively modulated by Bt2cAMP in neuroblastoma cells. Neuroblastoma cell lines have frequently been used as models for the study of neuronal development. When treated with Bt2cAMP or other inducers, these cells acquire many of the properties of mature neurons, such as extension of neurites (9, 24) , induction of enzymes for neurotransmitter synthesis (25, 26) , and acquisition of excitable membranes (27) . Other agents that have been shown to affect differentiation in neuroblastoma cells also induce elevated levels of cAMP, thus leading to the proposal that the cyclic nucleotide regulates the key events in the differentiation process (28, 29) . Inherent in the regulation of these events are changes in the amount of synthesis of specific proteins, some of which have been correlated with parallel changes in the level of the respective mRNA species (11, 30) . On the molecular level it was shown by using cDNA probes that the sequence complexity of RNA isolated from both neuroblastoma and glioma cells is greater than in other somatic lines. This finding is in accord with the greater degree of complexity found in total brain mRNA as compared with other organs (31, 32) .
One of the earliest events evident after administration of Bt2cAMP to neuroblastoma cells is a marked flattening of the cells (within 1 hr); we assumed that at least one of the primary events regulated by this agent might involve alterations in cvtoskeletal protein synthesis. Our (12) . It has also been shown that the increase in the level of unpolymerized tubulin obtained by colchicine treatment affects, directly or indirectly, the level of tubulin mRNA (13, 36, 37) . It is possible that a similar mechanism controls one of the phases of the mRNA expression in response to Bt2cAMP treatment. It should be noted that in recent studies from our laboratory it was found that the regulation of tubulin mRNA expression is more complicated than initially postulated; the results suggested the existence of more than one independent regulatory site for tubulin expression (13) .
It has also been observed that changes in the cellular cAMP level may regulate the differential synthesis and turnover of two types of cAMP-dependent protein kinases (38, 39) . These effects might be brought about by the addition of exogenous Bt2cAMP to neuroblastoma cells in culture. The control of the two stages of tubulin mRNA levels can be explained by cAMP differentially affecting two different cAMP-dependent protein kinases; the mechanism for exerting two effector roles for cAMP may lie in the temporally discrete activation of the appropriate type of protein kinase. The ratio of these two activities may determine the balance between the proliferative and differentiation stages of these cells.
